Twitter
Google plus
Facebook
Vimeo
Pinterest

Fluid Edge Themes

News

07/2020 – Authority Magazine

The Future Of Beauty: Stem Cell Technology To Improve Skin And Hair, With Habib Torfi of Invitrx Therapeutics

Your body is the most important part of staying healthy and beautiful. I basically recommend people a healthy diet, exercise, good sleeping

Read More

11/2020 – Bio Informant

Invitrx Therapeutics to Co-Sponsor Baylx, Inc’s US FDA Approved Umbilical Cord Tissue Mesenchymal Stem Cells Product for COVID-19

Invitrx Therapeutics has formally signed a joint venture agreement with Baylx, Inc. (Baylx), to co-sponsor Baylx’s FDA approved Investigational

Read More

12/2020 – ACCESSWIRE

Invitrx Therapeutics Profiled on BioInformant About Co-Sponsoring Baylx, Inc's US FDA Approved Umbilical Cord Tissue Mesenchymal Stem Cells Product for COVID-19

Invitrx Therapeutics, headquartered in Irvine, California, is a global research-based life science company with more than 10 years of experience

Read More

12/2020 – Yahoo Finance

Invitrx Therapeutics Profiled on BioInformant About Co-Sponsoring Baylx, Inc's US FDA Approved Umbilical Cord Tissue Mesenchymal Stem Cells Product for COVID-19

Invitrx Therapeutics, headquartered in Irvine, California, is a global research-based life science company with more than 10 years of experience

Read More

12/2020 – AP News

Invitrx Therapeutics Profiled on BioInformant About Co-Sponsoring Baylx, Inc’s US FDA Approved Umbilical Cord Tissue Mesenchymal Stem Cells Product for COVID-19

Invitrx Therapeutics, headquartered in Irvine, California, is a global research-based life science company with more than 10 years of experience

Read More

12/2020 – Digital Journal

Invitrx Therapeutics Profiled on BioInformant About Co-Sponsoring Baylx, Inc's US FDA Approved Umbilical Cord Tissue Mesenchymal Stem Cells Product for COVID-19

Invitrx Therapeutics’ continued efforts to be the leader in innovative cellular therapy had just recently been reinforced with the company’s collaboration with Baylx, Inc.

Read More

12/2020 – Fox 34

Invitrx Therapeutics Profiled on BioInformant About Co-Sponsoring Baylx, Inc's US FDA Approved Umbilical Cord Tissue Mesenchymal Stem Cells Product for COVID-19

Invitrx Therapeutics, headquartered in Irvine, California, is a global research-based life science company with more than 10 years of experience

Read More

12/2020 – Science Tech Today

INVITRX THERAPEUTICS PROFILED ON BIOINFORMANT ABOUT CO-SPONSORING BAYLX, INC'S US FDA APPROVED UMBILICAL CORD TISSUE MESENCHYMAL STEM CELLS PRODUCT FOR COVID-19

Invitrx Therapeutics’ continued efforts to be the leader in innovative cellular therapy had just recently been reinforced with the company’s collaboration with Baylx, Inc.

Read More

12/2020 Technology – In The Headline

Invitrx Therapeutics Profiled On BioInformant About Co-Sponsoring Baylx, Inc's US FDA Approved Umbilical Cord Tissue Mesenchymal Stem Cells Product For COVID-19

Invitrx Therapeutics’ continued efforts to be the leader in innovative cellular therapy had just recently been reinforced with the company’s collaboration with Baylx, Inc.

Read More

12/2020 – Finance Asean Coverage

Invitrx Therapeutics Profiled on BioInformant About Co-Sponsoring Baylx, Inc's US FDA Approved Umbilical Cord Tissue Mesenchymal Stem Cells Product for COVID-19

Invitrx Therapeutics’ continued efforts to be the leader in innovative cellular therapy had just recently been reinforced with the company’s collaboration with Baylx, Inc.

Read More